| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 23,276.0 | 22,386.0 |
| Net income | 4,731.0 | 4,750.0 |
| EPS (diluted, $ a share) | $1.97 | $1.95 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -0.4% |
|---|---|
| Revenue, year on year | +4.0% |
| Operating margin | 25.5% |
10-Q filed with the SEC, NYSE: PG. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Procter & Gamble Co: key numbers
- Share price
- $173.02Close, Nov 16
- Market cap
- $401B
- Shares outstanding
- 2.32BLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsSIC 2840
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Co
All →Procter & Gamble CEO-Baby and Feminine Care El Hak Hesham Abd Sells $379K of Stock
El Hak Hesham Abd, CEO-Baby and Feminine Care, sold 2,250 shares of Procter & Gamble Co at $168.47 a share, worth $379K in total on Nov 12, 2026. Shares held after the trade: 8,968 (-20.1%).
- Value
- $379K
- Shares
- 2,250
- Price
- $168.47
- Role
- CEO-Baby and Feminine Care
- Holding change
- -20.1%
- Trade date
- Nov 12, 2026
Procter & Gamble CFO Andre Schulten Sells $5.18M of Stock
Andre Schulten, CFO, sold 30,677 shares of Procter & Gamble Co at $169.00 a share, worth $5.18M in total on Nov 5, 2026. Shares held after the trade: 65,618 (-31.9%).
- Value
- $5.18M
- Shares
- 30,677
- Price
- $169.00
- Role
- CFO
- Holding change
- -31.9%
- Trade date
- Nov 5, 2026
Procter & Gamble CEO - Grooming de Azevedo Juliana Monteiro Santos Sells $908K of Stock
de Azevedo Juliana Monteiro Santos, CEO - Grooming, sold 5,370 shares of Procter & Gamble Co at $169.00 a share, worth $908K in total on Nov 5, 2026. Shares held after the trade: 21,361 (-20.1%).
- Value
- $908K
- Shares
- 5,370
- Price
- $169.00
- Role
- CEO - Grooming
- Holding change
- -20.1%
- Trade date
- Nov 5, 2026
Procter & Gamble Debt Financing Update
The Procter & Gamble Company closed an underwritten public offering of four tranches of Euro-denominated notes totaling €3.25 billion in aggregate principal amount. The offering includes notes maturing in 2030, 2034, 2038, and 2046 with interest rates ranging from 3.750% to 4.625%.
- Term
- Through Nov 2046
Procter & Gamble SVP - CAO Matthew W. Janzaruk Sells $1.55M of Stock
Matthew W. Janzaruk, SVP - CAO, sold 9,479 shares of Procter & Gamble Co at $163.00 a share, worth $1.55M in total on Nov 3, 2026. Shares held after the trade: 1,271 (-88.2%).
- Value
- $1.55M
- Shares
- 9,479
- Price
- $163.00
- Role
- SVP - CAO
- Holding change
- -88.2%
- Trade date
- Nov 3, 2026
Procter & Gamble CEO- Health Care Paul Gama Sells $478K of Stock
Paul Gama, CEO- Health Care, sold 2,894 shares of Procter & Gamble Co at $165.00 a share, worth $478K in total on Oct 30, 2026. Shares held after the trade: 43,899 (-6.2%).
- Value
- $478K
- Shares
- 2,894
- Price
- $165.00
- Role
- CEO- Health Care
- Holding change
- -6.2%
- Trade date
- Oct 30, 2026